Austin Health

Title
The economic burden of idiopathic pulmonary fibrosis in Australia: a cost of illness study.
Publication Date
2022-10-27
Author(s)
Cox, Ingrid A
de Graaff, Barbara
Ahmed, Hasnat
Campbell, Julie
Otahal, Petr
Corte, Tamera J
Moodley, Yuben
Goh, Nicole S L
Hopkins, Peter
Macansh, Sacha
Walters, E Haydn
Palmer, Andrew J
Subject
Cost of illness
Economic burden
Heath resource utilization
Idiopathic pulmonary fibrosis
Type of document
Journal Article
OrcId
0000-0001-5130-4088
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
DOI
10.1007/s10198-022-01538-7
Abstract
Idiopathic pulmonary fibrosis (IPF) is a type of interstitial lung disease found mostly in elderly persons, characterized by a high symptom burden and frequent encounters with health services. This study aimed to quantify the economic burden of IPF in Australia with a focus on resource utilization and associated direct costs.
Link
link
Citation
The European Journal of Health Economics : HEPAC 2022
Jornal Title
The European Journal of Health Economics : HEPAC
ISSN
1618-7601

Files:

NameSizeformatDescriptionLink